Recipharm and Isofol Medical in Exclusive Drug Development

29.08.2014 - Two Swedish drugmakers, Recipharm and Isofol Medical, have agreed to collaborate to strengthen the development program of Isofol's lead drug candidate Modufolin, an endogenous...